SEARCH

SEARCH BY CITATION

References

  • 1
    Jafarzadeh A, Esmaeeli-Nadimi A, Nemati M, Tahmasbi M, Ahmadi P. Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease. East Mediterr Health J 2010;16:103944.
  • 2
    Niccoli G, Franceschi F, Cosentino N, Guipponi B, De Marco G, Merra G, et al. Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis 2010;21:21721.
  • 3
    Agrawal RP, Sharma R, Garg D, Pokharna R, Kochar DK, Kothari RP. Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes. J Indian Med Assoc 2010;108:1403.
  • 4
    Schimke K, Chubb SA, Davis WA, Davis TM. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010;212:3216.
  • 5
    Huang B, Chen Y, Xie Q, Lin G, Wu Y, Feng Y, et al. CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease. Dig Dis Sci 2011;56:10914.
  • 6
    Fagoonee S, De Angelis C, Elia C, Silvano S, Oliaro E, Rizzetoo M, Pellicano R. Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis? Minerva Med 2010;101:1215.
  • 7
    Ataseven H, Demir M, Gen R. Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. South Med J 2010;103:98892.
  • 8
    Ojetti V, Pellicano R, Fagoonee S, Migneco A, Berrutti M, Gasbarrini A. Helicobacter pylori infection and diabetes. Minerva Med 2010;101:1159.
  • 9
    Behroozian R, Moradkhan E. The assessment of probable relationship between lung cancer and Helicobacter pylori infection. Trop Gastroenterol 2010;31:346.
  • 10
    Rivière F, Roux X, Méchaï F, Imbert P, Rapp C. Cured pulmonary sarcoïdosis and Helicobacter pylori eradication: cause or coincidence?. Presse Med 2011; 40: 7657.
  • 11
    Veneri D, Bonani A, Franchini M, Fedrizzi A, Pizzolo G. Idiopathic thrombocytopenia and Helicobacter pylori infection: platelet count increase and early eradication therapy. Blood Transfus 2011;9:3402.
  • 12
    Godeau B, Michel M. Treatment of chronic immune thrombocytopenic purpura in adults. Ann Hematol 2010; Apr 14. [Epub ahead of print].
  • 13
    Kikuchi T, Kobayashi T, Yamashita T, Ohashi K, Sakamaki H, Akiyama H. Eight-year follow-up of patients with immune thrombocytopenic purpura related to H. pylori infection. Platelets 2011;22:5962.
  • 14
    Fan H, Zhu HL, Li SX, Lu XC, Zhai B, Guo B, et al. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura. Cell Biochem Biophys 2011;59:712.
  • 15
    Matsukawa Y, Iwamoto M, Kato K, Mizuno S, Gon Y, Hemmi A, et al. Long term changes in platelet counts after H. pylori eradication in non-ITP patients. Platelets 2010;21:62831.
  • 16
    Gursel O, Atay AA, Kurekci AE, Avcu F, Nevruz O, Senses Z, et al. Platelet aggregation in children with Helicobacter pylori infection. Clin Appl Thromb Hemost 2010;16:63742.
  • 17
    Diamantidis MD, Ioannidou-Papagiannaki E, Kountouras J, Manala E, Tsapournas G, Frida-Michailidou I, et al. High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes. Acta Haematol 2010;124:1419.
  • 18
    Matsukawa Y, Gon Y, Hemmi A, Takeuchi J, Sawada S, Hayashi I. Increases in nonspecific immunoglobulin E and eosinophils after H. pylori eradication. Case Rep Gastroenterol 2010;4:415.
  • 19
    Rahbani-Nobar MB, Javadzadeh A, Ghojazadeh L, Rafeey M, Ghorbanihaghjo A. The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy. Mol Vis 2010;17:99103.
  • 20
    Kim JM, Kim SH, Park KH, Han SY, Shim HS. Investigation of the association between Helicobacter pylori infection and normal tension glaucoma. Invest Ophthalmol Vis Sci 2010;52:6658.
  • 21
    Akashi R, Ishiguro N, Shimizu S, Kawashima M. Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol 2010; Nov 22. doi: 10.1111/j.1346-8138.2010.01106.x. [Epub ahead of print]
  • 22
    Zou QH, Li RQ. Helicobacter pylori in the oral cavity and gastric mucosa: a meta-analysis. J Oral Pathol Med 2010;40:31724. Epub 2011 Feb 5.
  • 23
    Ki MR, Goo MJ, Park JK, Hong IH, Ji AR, Han SY, et al. Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-beta1-induced inflammatory signaling. Lab Invest 2010;90:150716.
  • 24
    Lee JW, Lee DH, Lee JI, et al. Identification of Helicobacter pylori in gallstone, bile, and other hepatobiliary tissues of patients with cholecystitis. Gut Liver 2010;4:607.
  • 25
    Jesnowski R, Isaksson B, Mohrcke C, Bertsch C, Bulajic M, Schneider-Brachert W, et al. Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology 2010;10:4626.
  • 26
    Dobbs SM, Dobbs RJ, Weller C, Charlett A, Bjarnason IT, Lawson AJ, et al. Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism. Helicobacter 2010;15:27994.
  • 27
    Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Chatzigeorgiou S, et al. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 2010;23:199204.